These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 8398262

  • 1. Reversal of multidrug resistance by a new lipophilic cationic molecule, S9788. Comparison with 11 other MDR-modulating agents in a model of doxorubicin-resistant rat glioblastoma cells.
    Huet S, Chapey C, Robert J.
    Eur J Cancer; 1993; 29A(10):1377-83. PubMed ID: 8398262
    [Abstract] [Full Text] [Related]

  • 2. [Effect of quinine on the multiple drug resistance and intracellular distribution of pirarubicin in LR73 tumor cells: a comparative study with verapamil and S9788 by confocal laser microspectrofluorometry].
    Belhoussine R, Morjani H, Manfait M.
    Bull Cancer; 1997 Apr; 84(4):343-9. PubMed ID: 9238156
    [Abstract] [Full Text] [Related]

  • 3. Effect of S9788, cyclosporin A and verapamil on intracellular distribution of THP-doxorubicin in multidrug-resistant K562 tumor cells, as studied by laser confocal microspectrofluorometry.
    Sebille S, Morjani H, Poullain MG, Manfait M.
    Anticancer Res; 1994 Apr; 14(6A):2389-93. PubMed ID: 7825978
    [Abstract] [Full Text] [Related]

  • 4. Effect of duration of exposure to S9788, cyclosporin A or verapamil on sensitivity of multidrug resistant cells to vincristine or doxorubicin.
    Pérez V, Pierré A, Léonce S, Anstett M, Atassi G.
    Anticancer Res; 1993 Apr; 13(4):985-90. PubMed ID: 8352569
    [Abstract] [Full Text] [Related]

  • 5. [In vitro characterization of S9788, a new modulator of multidrug resistance].
    Pérez V, Pierré A, Léonce S, Anstett M, Prost JF, Atassi G.
    Bull Cancer; 1993 Apr; 80(4):310-25. PubMed ID: 8173185
    [Abstract] [Full Text] [Related]

  • 6. Comparative evaluation of S9788, verapamil, and cyclosporine A in K562 human leukemia cell lines and in P-glycoprotein-expressing samples from patients with hematologic malignancies.
    Merlin JL, Guerci A, Marchal S, Missoum N, Ramacci C, Humbert JC, Tsuruo T, Guerci O.
    Blood; 1994 Jul 01; 84(1):262-9. PubMed ID: 7912556
    [Abstract] [Full Text] [Related]

  • 7. Influence of S9788, a new modulator of multidrug resistance, on the cellular accumulation and subcellular distribution of daunorubicin in P-glycoprotein-expressing MCF7 human breast adenocarcinoma cells.
    Merlin JL, Marchal S, Ramacci C, Dieterlen A, Schultz G, Lucas C, Poullain MG, Berlion M.
    Cytometry; 1995 Aug 01; 20(4):315-23. PubMed ID: 7587719
    [Abstract] [Full Text] [Related]

  • 8. Effects of a new triazinoaminopiperidine derivative on adriamycin accumulation and retention in cells displaying P-glycoprotein-mediated multidrug resistance.
    Léonce S, Pierré A, Anstett M, Pérez V, Genton A, Bizzari JP, Atassi G.
    Biochem Pharmacol; 1992 Nov 03; 44(9):1707-15. PubMed ID: 1360210
    [Abstract] [Full Text] [Related]

  • 9. [Pharmacological properties of S9788, a new modulator of multidrug resistance].
    Bull Cancer; 1994 Feb 03; 81(2):93-103. PubMed ID: 7894124
    [Abstract] [Full Text] [Related]

  • 10. Multidrug resistance circumvention by a new triazinoaminopiperidine derivative S9788 in vitro: definition of the optimal schedule and comparison with verapamil.
    Julia AM, Roché H, Berlion M, Lucas C, Milano G, Robert J, Bizzari JP, Canal P.
    Br J Cancer; 1994 May 03; 69(5):868-74. PubMed ID: 8180016
    [Abstract] [Full Text] [Related]

  • 11. Evidence for reversal of multidrug resistance by quinine in LR73 cells without alteration of nuclear pirarubicin uptake and down-regulation of mdr1 gene expression.
    Belhoussine R, Morjani H, Lahlil R, Manfait M.
    Int J Cancer; 1997 Nov 14; 73(4):600-6. PubMed ID: 9389578
    [Abstract] [Full Text] [Related]

  • 12. [Effect of S9788, cyclosporin A and verapamil on intracellular accumulation of doxorubicin, daunorubicin and daunorubicinol in primary rat hepatocyte culture].
    Le Bot MA, Kernaleguen D, Simon I, Berlion M, Riché C.
    Ann Biol Clin (Paris); 1996 Nov 14; 54(1):21-4. PubMed ID: 8731791
    [Abstract] [Full Text] [Related]

  • 13. Differential effectiveness of a range of novel drug-resistance modulators, relative to verapamil, in influencing vinblastine or teniposide cytotoxicity in human lymphoblastoid CCRF-CEM sublines expressing classic or atypical multidrug resistance.
    Hill BT, Hosking LK.
    Cancer Chemother Pharmacol; 1994 Nov 14; 33(4):317-24. PubMed ID: 8281626
    [Abstract] [Full Text] [Related]

  • 14. Differential effects of verapamil and quinine on the reversal of doxorubicin resistance in a human leukemia cell line.
    Bennis S, Ichas F, Robert J.
    Int J Cancer; 1995 Jul 28; 62(3):283-90. PubMed ID: 7628869
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of S9788 as a potential modulator of drug resistance against human tumour sublines expressing differing resistance mechanisms in vitro.
    Hill BT, van der Graaf WT, Hosking LK, de Vries EG, Mulder NH, Whelan RD.
    Int J Cancer; 1993 Sep 09; 55(2):330-7. PubMed ID: 8103761
    [Abstract] [Full Text] [Related]

  • 16. Relationship between the inhibition of azidopine binding to P-glycoprotein by MDR modulators and their efficiency in restoring doxorubicin intracellular accumulation.
    Hu YP, Chapey C, Robert J.
    Cancer Lett; 1996 Dec 03; 109(1-2):203-9. PubMed ID: 9020922
    [Abstract] [Full Text] [Related]

  • 17. S9788 modulation of P-glycoprotein- and Multidrug-related protein-mediated multidrug resistance by Servier 9788 in doxorubicin-resistant MCF7 cells.
    Bichat F, Solis-Recendez G, Poullain MG, Poupon MF, Khayat D, Bastian G.
    Biochem Pharmacol; 1998 Aug 15; 56(4):497-502. PubMed ID: 9763226
    [Abstract] [Full Text] [Related]

  • 18. Combined use of tamoxifen, cyclosporin A, and verapamil for modulating multidrug resistance in human hepatocellular carcinoma cell lines.
    Kim JH, Chung JB, Park IS, Kim BS, Yoo NC, Choi JH, Roh JK, Kim HS, Kwon OH, Lee KS.
    Yonsei Med J; 1993 Mar 15; 34(1):35-44. PubMed ID: 8397460
    [Abstract] [Full Text] [Related]

  • 19. Effects of verapamil and S9788 on MDR-1 mRNA expression studied by in situ hybridization.
    Joly P, Lallemand A, Oum'Hamed Z, Trentesaux C, Idoine O, Desplaces A.
    Anticancer Res; 1996 Mar 15; 16(6B):3609-14. PubMed ID: 9042229
    [Abstract] [Full Text] [Related]

  • 20. Cyclosporin A, verapamil and S9788 reverse doxorubicin resistance in a human medullary thyroid carcinoma cell line.
    Massart C, Gibassier J, Raoul M, Pourquier P, Leclech G, Robert J, Lucas C.
    Anticancer Drugs; 1995 Feb 15; 6(1):135-46. PubMed ID: 7756676
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.